Mead Johnson Nutrition CO Company Profile (NYSE:MJN)

About Mead Johnson Nutrition CO (NYSE:MJN)

Mead Johnson Nutrition CO logoMead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children's milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company marketed its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe, as of December 31, 2016.

Industry, Sector and Symbol:
  • Sector: Non-Cyclical Consumer Goods & Services
  • Industry: Baby Food
  • Sub-Industry: Packaged Foods & Meats
  • Symbol: NYSE:MJN
  • CUSIP: 58283910
  • Web:
Average Prices:
  • 50 Day Moving Avg: $89.62
  • 200 Day Moving Avg: $84.34
  • 52 Week Range: $69.25 - $94.40
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 26.16
  • P/E Growth: 0.00
  • Net Margins: 13.31%
  • Return on Assets: 11.35%
  • Debt-to-Equity Ratio: -7.57%
  • Current Ratio: 2.15%
  • Quick Ratio: 1.77%
  • Average Volume: 1.93 million shs.
  • Beta: 1.57

Frequently Asked Questions for Mead Johnson Nutrition CO (NYSE:MJN)

What is Mead Johnson Nutrition CO's stock symbol?

Mead Johnson Nutrition CO trades on the New York Stock Exchange (NYSE) under the ticker symbol "MJN."

How often does Mead Johnson Nutrition CO pay dividends? What is the dividend yield for Mead Johnson Nutrition CO?

Mead Johnson Nutrition CO announced a quarterly dividend on Wednesday, May 31st. Shareholders of record on Tuesday, June 20th will be paid a dividend of $0.4125 per share on Wednesday, July 5th. This represents a $1.65 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date is Friday, June 16th. View Mead Johnson Nutrition CO's Dividend History.

How were Mead Johnson Nutrition CO's earnings last quarter?

Mead Johnson Nutrition CO (NYSE:MJN) announced its earnings results on Thursday, April, 27th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.01. The company had revenue of $883.50 million for the quarter, compared to analysts' expectations of $911.63 million. Mead Johnson Nutrition CO's quarterly revenue was down 8.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.87 EPS. View Mead Johnson Nutrition CO's Earnings History.

Where is Mead Johnson Nutrition CO's stock going? Where will Mead Johnson Nutrition CO's stock price be in 2017?

10 equities research analysts have issued 1-year target prices for Mead Johnson Nutrition CO's stock. Their predictions range from $66.00 to $90.00. On average, they expect Mead Johnson Nutrition CO's share price to reach $83.50 in the next twelve months. View Analyst Ratings for Mead Johnson Nutrition CO.

Who are some of Mead Johnson Nutrition CO's key competitors?

Who are Mead Johnson Nutrition CO's key executives?

Mead Johnson Nutrition CO's management team includes the folowing people:

  • Peter Kasper Jakobsen, President, Chief Executive Officer, Director
  • Michel M.G. Cup, Chief Financial Officer, Executive Vice President
  • Charles M. Urbain, Chief Operating Officer, Executive Vice President
  • Patrick M. Sheller, Senior Vice President, General Counsel, Secretary
  • James E. Shiah, Senior Vice President, Corporate Controller
  • James Jeffrey Jobe, Senior Vice President - Technical Operations
  • Ian Eric Ormesher, Senior Vice President- Global Human Resources
  • Dirk Hondmann Ph.D., Chief Scientific Officer
  • James M. Cornelius, Non-Executive Chairman of the Board
  • Elliot Sigal M.D. Ph.D., Director

How do I buy Mead Johnson Nutrition CO stock?

Shares of Mead Johnson Nutrition CO can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mead Johnson Nutrition CO's stock price today?

One share of Mead Johnson Nutrition CO stock can currently be purchased for approximately $89.99.

MarketBeat Community Rating for Mead Johnson Nutrition CO (NYSE MJN)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  331 (Vote Outperform)
Underperform Votes:  402 (Vote Underperform)
Total Votes:  733
MarketBeat's community ratings are surveys of what our community members think about Mead Johnson Nutrition CO and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Mead Johnson Nutrition CO (NYSE:MJN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 10 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $83.50 (7.21% downside)
Consensus Price Target History for Mead Johnson Nutrition CO (NYSE:MJN)
Price Target History for Mead Johnson Nutrition CO (NYSE:MJN)
Analysts' Ratings History for Mead Johnson Nutrition CO (NYSE:MJN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/5/2017Canaccord GenuityReiterated RatingSpeculative BuyLowView Rating Details
6/15/2017BMO Capital MarketsReiterated RatingHold$90.00LowView Rating Details
4/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market Perform$89.00LowView Rating Details
4/1/2017Susquehanna Bancshares IncSet Price TargetHold$78.00 -> $90.00LowView Rating Details
3/6/2017Citigroup Inc.DowngradeBuy -> NeutralN/AView Rating Details
3/5/2017Credit Suisse GroupDowngradeOutperform -> Neutral$90.00N/AView Rating Details
2/13/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017Berenberg BankUpgradeSell -> Hold$66.00N/AView Rating Details
10/28/2016Deutsche Bank AGLower Price TargetHold$85.00 -> $78.00N/AView Rating Details
10/28/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$90.00 -> $75.00N/AView Rating Details
9/27/2016Goldman Sachs Group IncLower Price TargetNeutral$96.00 -> $85.00N/AView Rating Details
7/29/2016Societe GeneraleDowngradeBuy -> Hold$100.00 -> $95.00N/AView Rating Details
7/13/2016Bank of America CorporationUpgradeUnderperform -> Neutral$93.00N/AView Rating Details
2/1/2016NomuraBoost Price TargetNeutral$85.00 -> $88.00N/AView Rating Details
(Data available from 10/21/2015 forward)


Earnings History for Mead Johnson Nutrition CO (NYSE:MJN)
Earnings by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Earnings History by Quarter for Mead Johnson Nutrition CO (NYSE MJN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017Q1 17$0.79$0.80$911.63 million$883.50 millionViewN/AView Earnings Details
1/26/2017Q416$0.81$0.78$928.84 million$901.60 millionViewListenView Earnings Details
10/27/2016Q316$0.86$0.87$933.43 million$937.50 millionViewListenView Earnings Details
7/28/2016Q216$0.78$0.88$967.25 million$941.50 millionViewListenView Earnings Details
4/28/2016Q116$0.85$0.87$957.03 million$962.10 millionViewListenView Earnings Details
1/28/2016Q415$0.73$0.78$971.23 million$967.00 millionViewListenView Earnings Details
10/22/2015Q315$0.85$0.80$1.03 billion$977.50 millionViewListenView Earnings Details
7/23/2015Q215$0.77$0.76$1.10 billion$1.03 billionViewListenView Earnings Details
4/23/2015Q115$1.05$1.09$1.13 billion$1.09 billionViewListenView Earnings Details
1/29/2015Q414$0.88$0.92$1.11 billion$1.09 billionViewListenView Earnings Details
10/23/2014Q314$0.91$0.93$1.08 billion$1.09 billionViewListenView Earnings Details
7/22/2014Q214$0.89$0.88$1.10 billion$1.11 billionViewListenView Earnings Details
4/24/2014Q114$0.91$1.02$1.10 billion$1.11 billionViewListenView Earnings Details
1/31/2014Q413$0.77$0.78$1.05 billion$1.06 billionViewListenView Earnings Details
10/24/2013Q313$0.79$0.91$998.04 million$1.05 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.83$0.84$1.04 billion$1.06 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.85$0.85$1.02 billion$1.04 billionViewListenView Earnings Details
1/31/2013Q4 2012$0.68$0.72$953.84 million$981.10 millionViewListenView Earnings Details
10/25/2012$0.72$0.71ViewN/AView Earnings Details
7/26/2012$0.76$0.83ViewN/AView Earnings Details
4/26/2012$0.78$0.82ViewN/AView Earnings Details
1/26/2012$0.51$0.52ViewN/AView Earnings Details
10/27/2011$0.77$0.78ViewN/AView Earnings Details
7/28/2011$0.69$0.72ViewN/AView Earnings Details
4/28/2011$0.72$0.76ViewN/AView Earnings Details
1/27/2011$0.56$0.57ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Mead Johnson Nutrition CO (NYSE:MJN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171$0.74$0.74$0.74
Q3 20171$0.83$0.83$0.83
Q4 20171$0.83$0.83$0.83
(Data provided by Zacks Investment Research)


Current Dividend Information for Mead Johnson Nutrition CO (NYSE:MJN)
Most Recent Dividend:7/5/2017
Annual Dividend:$1.65
Dividend Yield:1.83%
Dividend Growth:7.70% (3 Year Average)
Payout Ratio:51.72% (Trailing 12 Months of Earnings)
50.00% (Based on This Year's Estimates)
47.97% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)

Dividend History by Quarter for Mead Johnson Nutrition CO (NYSE MJN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Mead Johnson Nutrition CO (NYSE:MJN)
Insider Ownership Percentage: 0.50%
Institutional Ownership Percentage: 88.40%
Insider Trades by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Institutional Ownership by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Insider Trades by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/31/2016Anna C CatalanoDirectorSell656$74.99$49,193.44View SEC Filing  
8/15/2016Kimberly A CasianoDirectorSell710$89.75$63,722.50View SEC Filing  
8/5/2016Graciela MonteagudoSVPSell45,873$87.64$4,020,309.72View SEC Filing  
5/2/2016Christoper Richard StrattonSVPSell33,730$86.66$2,923,041.80View SEC Filing  
12/14/2015Michel Martinus Gerardus CupCFOBuy4,000$76.50$306,000.00View SEC Filing  
11/25/2015Robert S SingerDirectorSell4,000$81.77$327,080.00View SEC Filing  
9/2/2015Anna C CatalanoDirectorSell1,125$76.60$86,175.00View SEC Filing  
9/1/2015Kimberly A CasianoDirectorSell1,138$76.61$87,182.18View SEC Filing  
8/24/2015James M CorneliusDirectorBuy10,000$77.10$771,000.00View SEC Filing  
8/20/2015Howard B. BernickDirectorBuy5,000$79.95$399,750.00View SEC Filing  
7/27/2015James M CorneliusDirectorBuy10,000$89.03$890,300.00View SEC Filing  
5/13/2015Weerdt Tom DeVPSell7,585$95.64$725,429.40View SEC Filing  
5/8/2015Robert S SingerDirectorSell5,000$95.81$479,050.00View SEC Filing  
5/1/2015Charles M UrbainSVPSell5,000$95.89$479,450.00View SEC Filing  
4/30/2015Howard B BernickDirectorBuy4,000$96.33$385,320.00View SEC Filing  
4/15/2015Stephen W GolsbyDirectorSell5,000$101.31$506,550.00View SEC Filing  
3/16/2015Stephen W GolsbyDirectorSell5,000$100.00$500,000.00View SEC Filing  
2/17/2015Stephen W GolsbyDirectorSell5,000$101.39$506,950.00View SEC Filing  
2/3/2015James M CorneliusDirectorBuy10,000$99.78$997,800.00View SEC Filing  
2/2/2015Charles M UrbainSVPSell5,000$98.34$491,700.00View SEC Filing  
1/15/2015Stephen W GolsbyDirectorSell5,000$99.11$495,550.00View SEC Filing  
12/24/2014William P'poolVPSell21,375$101.22$2,163,577.50View SEC Filing  
12/15/2014Stephen W GolsbyDirectorSell5,000$96.83$484,150.00View SEC Filing  
11/17/2014Stephen W GolsbyDirectorSell178,783$99.56$17,799,635.48View SEC Filing  
11/17/2014William P'poolVPSell19,879$99.99$1,987,701.21View SEC Filing  
11/14/2014Stephen W GolsbyDirectorSell5,000$99.20$496,000.00View SEC Filing  
11/3/2014Robert S SingerDirectorSell6,000$100.56$603,360.00View SEC Filing  
10/27/2014James J JobeSVPSell13,956$101.90$1,422,116.40View SEC Filing  
10/15/2014Stephen W GolsbyDirectorSell10,000$91.33$913,300.00View SEC Filing  
9/15/2014Stephen W GolsbyDirectorSell10,000$96.43$964,300.00View SEC Filing  
8/15/2014Stephen W GolsbyDirectorSell10,000$95.11$951,100.00View SEC Filing  
8/8/2014Peter G LeemputteCFOSell76,212$91.56$6,977,970.72View SEC Filing  
7/22/2014Dirk HondmannSVPSell15,668$97.00$1,519,796.00View SEC Filing  
7/15/2014Stephen W GolsbyDirectorSell10,000$93.83$938,300.00View SEC Filing  
6/18/2014Charles M UrbainSVPSell23,502$90.00$2,115,180.00View SEC Filing  
6/18/2014William P'poolVPSell5,659$90.00$509,310.00View SEC Filing  
6/16/2014Stephen W GolsbyDirectorSell10,000$87.42$874,200.00View SEC Filing  
5/30/2014Robert S SingerDirectorSell3,000$89.27$267,810.00View SEC Filing  
5/29/2014Dirk HondmannSVPSell14,559$87.83$1,278,716.97View SEC Filing  
5/29/2014Robert S SingerDirectorSell3,000$87.40$262,200.00View SEC Filing  
5/15/2014Stephen GolsbyDirectorSell10,000$85.76$857,600.00View SEC Filing  
5/14/2014Dirk HondmannSVPSell1,503$87.83$132,008.49View SEC Filing  
5/12/2014Dirk HondmannSVPSell6,355$87.00$552,885.00View SEC Filing  
4/15/2014Stephen GolsbyDirectorSell10,000$83.25$832,500.00View SEC Filing  
4/1/2014Charles UrbainSVPSell11,298$85.00$960,330.00View SEC Filing  
4/1/2014William P'poolVPSell8,405$85.00$714,425.00View SEC Filing  
3/14/2014Stephen GolsbyDirectorSell10,000$82.44$824,400.00View SEC Filing  
3/4/2014Stephen GolsbyDirectorSell104,452$83.41$8,712,341.32View SEC Filing  
2/21/2014Peter LeemputteCFOSell30,704$80.59$2,474,435.36View SEC Filing  
2/14/2014Stephen GolsbyDirectorSell10,000$77.78$777,800.00View SEC Filing  
1/15/2014Stephen GolsbyDirectorSell10,000$83.12$831,200.00View SEC Filing  
12/16/2013Stephen GolsbyDirectorSell10,000$82.68$826,800.00View SEC Filing  
11/15/2013Stephen GolsbyDirectorSell10,000$84.08$840,800.00View SEC Filing  
10/15/2013Stephen GolsbyDirectorSell10,000$75.28$752,800.00View SEC Filing  
9/16/2013Stephen GolsbyDirectorSell10,000$77.22$772,200.00View SEC Filing  
8/15/2013James CorneliusDirectorBuy10,000$75.99$759,900.00View SEC Filing  
7/15/2013Stephen W GolsbyDirectorSell10,000$74.15$741,500.00View SEC Filing  
6/14/2013Stephen W GolsbyDirectorSell10,000$82.09$820,900.00View SEC Filing  
5/15/2013Stephen W GolsbyDirectorSell10,000$79.97$799,700.00View SEC Filing  
4/30/2013Howard B BernickDirectorBuy3,511$82.38$289,236.18View SEC Filing  
11/15/2012Stephen W GolsbyCEOSell10,000$66.87$668,700.00View SEC Filing  
11/1/2012Peter G LeemputteCFOBuy3,000$63.61$190,830.00View SEC Filing  
10/31/2012James M CorneliusDirectorBuy10,000$61.75$617,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Mead Johnson Nutrition CO (NYSE:MJN)
Latest Headlines for Mead Johnson Nutrition CO (NYSE:MJN)
DateHeadline logo1 FTSE 100 growth stock I’d hold for 25 years alongside Unilever plc - October 18 at 7:03 AM logoReckitt Benckiser Misses Q3 Estimates, Cautions on Challenges Ahead - October 18 at 7:03 AM logoChina Dairy Giants Shake Off Scandal to Become Blue Chips - October 15 at 7:38 PM logoO'Keefe Reinhard & Paul Chicago has acquired Juice Interactive - October 12 at 6:53 AM logoGDL: Playing It Safe With Upside Potential - September 27 at 3:44 PM logoMead Johnson Nutrition CO (MJN) Given Consensus Rating of "Hold" by Analysts - September 16 at 8:40 PM logoNestle's Growth Supplements - September 12 at 1:45 AM logoReckitt Benckiser Says Four Top Executives Leave Amid Overhaul - September 4 at 5:48 AM logoBeaten at Home, Chinese Milk Formula Makers Forge Ties Abroad - September 1 at 5:24 AM logoMead Johnson Nutrition CO (MJN) Given Consensus Recommendation of "Hold" by Brokerages - August 22 at 8:44 PM logoGlobal Infant and Toddler Nutrition Market 2017-2021: Key Vendors are Mead Johnson, Danone, Nestle & Glanbia - August 15 at 1:42 AM logoMead Johnson Nutrition CO (NYSE:MJN) Given Consensus Rating of "Hold" by Analysts - July 28 at 8:46 PM logo[$$] Reckitt chief tries to find formula for Mead Johnson growth - July 25 at 12:11 AM logoMcCormick to Buy Reckitt Food Unit for $4 Billion, FT Says - July 18 at 11:30 PM logoMn Services Vermogensbeheer BV Buys Apple Inc, Microsoft Corp, Amazon. ... - Nasdaq - July 16 at 12:56 PM logoMead Johnson Nutrition Company (NYSE:MJN) Earns "Speculative Buy" Rating from Canaccord Genuity - July 5 at 4:26 PM logoMead Johnson Nutrition Company (MJN) Receives Consensus Rating of "Hold" from Brokerages - July 3 at 8:44 PM logoMead Johnson Nutrition Company (MJN) Sees Large Drop in Short Interest - July 3 at 7:04 AM logoFinal Approval Received For Acquisition Of Mead Johnson By Reckitt Benckiser - Nasdaq - June 13 at 5:52 AM logoReckitt to Close $18 Billion Mead Johnson Takeover - Investopedia - June 13 at 5:52 AM logoBRIEF-Mead Johnson receives final approval for acquisition of co by Reckitt Benckiser - June 12 at 3:55 PM logoMead Johnson Stockholders Approve Acquisition by RB; Mead Johnson Nutrition Board Announces Dividend - Business Wire (press release) - June 2 at 5:28 AM logoMead Johnson (MJN) Stockholders Approve Acquisition by Reckitt Benckiser - May 31 at 11:55 PM logoBRIEF-Mead Johnson stockholders approve acquisition by RB - May 31 at 11:55 PM logoPaul Singer Gains 9 New Holdings in 1st Quarter - Nasdaq - May 26 at 7:23 PM logoMead Johnson Nutrition Reports First Quarter 2017 Results - Business Wire (press release) - April 29 at 12:30 AM logoRisk Arbitrage Today: Dutch Auction In CIT Group - April 28 at 9:19 AM logoMead Johnson Nutrition: 2017 Earnings Guidance No Longer Applicable - April 27 at 9:39 AM logoBRIEF-Mead Johnson nutrition Q1 non-GAAP earnings per share $0.80 excluding items - April 27 at 9:39 AM logoMead Johnson Nutrition Co. Announces 65% Increase In Q1 Bottom Line - April 27 at 9:39 AM logoYieldBoost Mead Johnson Nutrition From 1.9% To 2.1% Using Options - April 25 at 5:53 PM logoMead Johnson Nutrition downgraded by Wells Fargo - April 3 at 5:50 PM logoFrank's Red Hot, French's Mustard Could Be Worth $3 Billion in a Sale - April 3 at 5:50 PM logo[$$] Reckitt Benckiser cuts CEO pay after investor revolt - March 31 at 9:37 AM logoReckitt Benckiser cuts CEO's pay by 39 percent after safety scandal - March 31 at 9:37 AM logoHow to Survive on Just $18 Million a Year - March 31 at 9:37 AM logoAccretive Analysis Of Reckitt Benckiser's Mead Johnson Nutrition Acquisition - March 28 at 6:18 PM logoBest Idea In The Merger Arb Universe: Reckitt Benckiser Swallows Up Infant Formula Maker - March 20 at 4:45 PM logoMead Johnson Nutrition Company (MJN) Ex-Dividend Date Scheduled for March 09, 2017 - Nasdaq - March 9 at 12:20 AM logoThe 3 Best-Performing Stocks in February - March 8 at 10:28 AM logoEx-Dividend Reminder: James River Group Holdings, Mead Johnson Nutrition and Icahn Enterprises - March 7 at 10:26 AM logoMEAD JOHNSON NUTRITION CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits - March 3 at 6:34 PM logoMead Johnson Board of Directors Announces Dividend - Business Wire (press release) - March 1 at 11:37 PM logoMEAD JOHNSON NUTRITION CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - March 1 at 6:36 PM logoMead Johnson Acquires Strategic Capabilities and Capacity in ... - Business Wire (press release) - February 28 at 6:41 PM logoMead Johnson buys supply chain assets in Australia - February 27 at 6:06 PM logoMead Johnson Acquires Strategic Capabilities and Capacity in Australia - February 27 at 6:06 PM logoMEAD JOHNSON NUTRITION CO Files SEC form 10-K, Annual Report - February 27 at 6:06 PM logo[$$] Reckitt Bags a Mead Johnson on the Mend - February 18 at 5:46 AM logoBUZZ-Unilever: analysts and investors question Kraft's 'inadequate' offer - February 17 at 3:17 PM



Mead Johnson Nutrition CO (MJN) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.